AKT1 and cancer: This phenomenon was somewhat supported by a recent study which found that BRAF mutations represented early events in thyroid carcinogenesis, whereas mutations of PIK3CA and AKT1 were latter events not found in the primary cancers, but in metastases or recurrent cancers [20].